1. Home
  2. PRTG vs IDAI Comparison

PRTG vs IDAI Comparison

Compare PRTG & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTG
  • IDAI
  • Stock Information
  • Founded
  • PRTG 1973
  • IDAI 2016
  • Country
  • PRTG British Virgin Islands
  • IDAI United States
  • Employees
  • PRTG N/A
  • IDAI N/A
  • Industry
  • PRTG Oil & Gas Production
  • IDAI Computer Software: Prepackaged Software
  • Sector
  • PRTG Energy
  • IDAI Technology
  • Exchange
  • PRTG Nasdaq
  • IDAI Nasdaq
  • Market Cap
  • PRTG 4.7M
  • IDAI 4.2M
  • IPO Year
  • PRTG N/A
  • IDAI N/A
  • Fundamental
  • Price
  • PRTG $5.69
  • IDAI $0.43
  • Analyst Decision
  • PRTG Hold
  • IDAI
  • Analyst Count
  • PRTG 1
  • IDAI 0
  • Target Price
  • PRTG N/A
  • IDAI N/A
  • AVG Volume (30 Days)
  • PRTG 1.9M
  • IDAI 52.2M
  • Earning Date
  • PRTG 11-26-2024
  • IDAI 11-15-2024
  • Dividend Yield
  • PRTG N/A
  • IDAI N/A
  • EPS Growth
  • PRTG N/A
  • IDAI N/A
  • EPS
  • PRTG N/A
  • IDAI N/A
  • Revenue
  • PRTG N/A
  • IDAI $2,160,186.00
  • Revenue This Year
  • PRTG N/A
  • IDAI N/A
  • Revenue Next Year
  • PRTG N/A
  • IDAI $95.88
  • P/E Ratio
  • PRTG N/A
  • IDAI N/A
  • Revenue Growth
  • PRTG N/A
  • IDAI N/A
  • 52 Week Low
  • PRTG $2.10
  • IDAI $0.15
  • 52 Week High
  • PRTG $40.80
  • IDAI $2.50
  • Technical
  • Relative Strength Index (RSI)
  • PRTG 56.00
  • IDAI 47.01
  • Support Level
  • PRTG $5.35
  • IDAI $0.36
  • Resistance Level
  • PRTG $12.89
  • IDAI $0.44
  • Average True Range (ATR)
  • PRTG 1.12
  • IDAI 0.12
  • MACD
  • PRTG 0.30
  • IDAI -0.03
  • Stochastic Oscillator
  • PRTG 31.57
  • IDAI 7.03

About PRTG Portage Biotech Inc.

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.

Share on Social Networks: